Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 301–400 of 1,020
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 155
SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure
Saw, J., Holmes, D. R., Cavalcante, J. L., Freeman, J. V., Goldsweig, A. M., Kavinsky, C. J., Moussa, I. D., Munger, T. M., Price, M. J., Reisman, M., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.01.007 · Cited by 155
Piccini, J. P., Fraulo, E. S., Ansell, J., Fonarow, G. C., Gersh, B. J., Go, A. S., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L. E., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.001 · Cited by 154
The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
Eikelboom, J. W., & Karthikeyan, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0757 · Cited by 155
(2016) · Europace · doi:10.1093/europace/euw242 · Cited by 126
Self-citationScreening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
Welton, N. J., McAleenan, A., Thom, H. H., Davies, P., Hollingworth, W., Higgins, J. P., Okoli, G., Sterne, J. A., Feder, G., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21290 · Cited by 141
Graham, D. J., Baro, E., Zhang, R., Liao, J., Wernecke, M., Reichman, M. E., Hu, M., Illoh, O. A., Wei, Y., Goulding, M. R., et al. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.12.023 · Cited by 154
Chen, J., Zhang, A., Lu, H., Guo, J., Wang, F., & Li, Z. (2013) · PubMed Central · doi:10.3969/j.issn.1671-5411.2013.03.004 · Cited by 165
Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation
Mason, P. K., Lake, D. E., DiMarco, J. P., Ferguson, J. D., Mangrum, J. M., Bilchick, K., Moorman, L. P., & Moorman, J. R. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.030 · Cited by 129
Faxon, D. P., Eikelboom, J. W., Berger, P. B., Holmes, D. R., Bhatt, D. L., Moliterno, D. J., Becker, R. C., & Angiolillo, D. J. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.111.965186 · Cited by 108
Atrial Fibrillation and Ischemic Stroke: A Clinical Review
Migdady, I., Russman, A., & Buletko, A. B. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726332 · Cited by 157
Galectin 3 and incident atrial fibrillation in the community
Ho, J. E., Yin, X., Levy, D., Vasan, R. S., Magnani, J. W., Ellinor, P. T., McManus, D. D., Lubitz, S. A., Larson, M. G., & Benjamin, E. J. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.009 · Cited by 118
Lee, R., Vassallo, P., Kruse, J. T., Malaisrie, S. C., Rigolin, V. H., Andrei, A., & McCarthy, P. M. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.06.009 · Cited by 151
Benedetto, U., Gaudino, M. F. L., Dimagli, A., Gerry, S., Gray, A. M., Lees, B., Flather, M. D., Taggart, D. P., Westaby, S., Cook, J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046940 · Cited by 156
Atrial fibrillation and stroke
Choi, S. E., Sagris, D., Hill, A. M., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2160319 · Cited by 152
Self-citationAtrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 151
Self-citationBerg, D. D., Ruff, C. T., Jarolím, P., Giugliano, R. P., Nordio, F., Lanz, H., Mercuri, M. F., Antman, E. M., Braunwald, E., & Morrow, D. A. (2019) · Circulation · doi:10.1161/circulationaha.118.038312 · Cited by 152
Lupercio, F. A., Ruiz, J. C., Briceno, D. F., Romero, J. E., Villablanca, P. A., Berardi, C., FAILLACE, R. T., KRUMERMAN, A. K., Fisher, J. D., Ferrick, K. J., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.042 · Cited by 149
Minimizing Blood Loss in Spine Surgery
Mikhail, C., Pennington, Z. A., Arnold, P. M., Brodke, D. S., Chapman, J. R., Chutkan, N. B., Daubs, M. D., DeVine, J. G., Fehlings, M. G., Gelb, D. E., et al. (2020) · Global Spine Journal · doi:10.1177/2192568219868475 · Cited by 148
Stewart, S., Ball, J., Horowitz, J. D., Marwick, T. H., Mahadevan, G., Wong, C., Abhayaratna, W. P., Chan, Y. K., Esterman, A., Thompson, D. R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61992-9 · Cited by 147
Paciaroni, M., Agnelli, G., Falocci, N., Tsivgoulis, G. K., Vadikolias, K., Liantinioti, C., Chondrogianni, M. E., Bovi, P., Carletti, M., Cappellari, M., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007034 · Cited by 147
Christopoulos, G., Graff-Radford, J., Lopez, C. L., Yao, X., Attia, Z. I., Rabinstein, A. A., Petersen, R. C., Knopman, D. S., Mielke, M. M., Kremers, W., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009355 · Cited by 126
Embolic Strokes of Undetermined Source in the Athens Stroke Registry: An Outcome Analysis
Ntaios, G., Papavasileiou, V., Milionis, H. J., Makaritsis, K. P., Vemmou, A., Korompoki, E., Manios, E. D., Spengos, K. M., Michel, P., & Vemmos, K. N. (2015) · Stroke · doi:10.1161/strokeaha.115.009334 · Cited by 145
Abdel-Qadir, H. M., Fang, J., Lee, D. S., Tu, J. V., Amir, E., Austin, P. C., & Anderson, G. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004580 · Cited by 145
Taha, A., Nielsen, S. J., Bergfeldt, L., Ahlsson, A., Friberg, L., Björck, S., Franzén, S., & Jeppsson, A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017966 · Cited by 145
Lubitz, S. A., Atlas, S. J., Ashburner, J. M., Lipsanopoulos, A. T. T., Borowsky, L. H., Guan, W., Khurshid, S., Ellinor, P. T., Chang, Y., McManus, D. D., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057014 · Cited by 126
Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · Heart · doi:10.1136/heartjnl-2017-312930 · Cited by 143
Self-citationLynam, A. L., Dennis, J. M., Owen, K. R., Oram, R. A., Jones, A. G., Shields, B. M., & Ferrat, L. A. (2020) · Diagnostic and Prognostic Research · doi:10.1186/s41512-020-00075-2 · Cited by 142
“These models are increasingly being used as web-calculators [7 – 9] and medical apps for smartphones [10 – 12], and many have been incorporated into clinical guidelines [13 – 17].”
MethodBohula, E. A., Wiviott, S. D., Giugliano, R. P., Blazing, M. A., Park, J.-G., Murphy, S. A., White, J. A., Mach, F., Van de Werf, F., Dalby, A. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029095 · Cited by 142
Role of the CHADS2 Score in Acute Coronary Syndromes
Poçi, D., Hartford, M., Karlsson, T., Herlitz, J. D., Edvardsson, N. G., & Caidahl, K. (2011) · CHEST Journal · doi:10.1378/chest.11-0435 · Cited by 142
Shen, J. I., Montez-Rath, M. E., Lenihan, C. R., Turakhia, M. P., Chang, T. I., & Winkelmayer, W. C. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.019 · Cited by 135
Venema, E., Mulder, M. J. H. L., Roozenbeek, B., Broderick, J. P., Yeatts, S. D., Khatri, P., Berkhemer, O. A., Emmer, B. J., Roos, Y. B. W. E. M., Majoie, C. B. L. M., et al. (2017) · BMJ · doi:10.1136/bmj.j1710 · Cited by 142
Penner, L. S., Gavan, S. P., Ashcroft, D. M., Peek, N. B., & Elliott, R. A. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15371 · Cited by 143
Hijazi, Z., Siegbahn, A., Andersson, U., Granger, C. B., Alexander, J. H., Atar, D., Gersh, B. J., Mohan, P., Harjola, V.-P., Horowitz, J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006286 · Cited by 128
Inohara, T., Shrader, P., Pieper, K., Blanco, R. G., Thomas, L., Singer, D. E., Freeman, J. V., Allen, L. A., Fonarow, G. C., Gersh, B., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4665 · Cited by 129
Chyou, J. Y., Barkoudah, E., Dukes, J. W., Goldstein, L. B., Joglar, J. A., Lee, A. M., Lubitz, S. A., Marill, K. A., Sneed, K., Streur, M. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001133 · Cited by 141
Higgins, P., MacFarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., & Lees, K. R. (2013) · Stroke · doi:10.1161/strokeaha.113.001927 · Cited by 127
Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 140
Adeboyeje, G., Sylwestrzak, G., Barron, J. J., White, J., Rosenberg, A., Abarca, J., Crawford, G., & Redberg, R. F. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.9.968 · Cited by 140
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 141
Self-citationXiong, Q., Lau, Y. C., Senoo, K., Lane, D. A., Hong, K., & Lip, G. Y. H. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.343 · Cited by 127
Self-citationRoldán, V., Marín, F. R., Muiña, B., Diaz, J. M. T., Hernández‐Romero, D., Valdés, M., Vicente, V., & Lip, G. Y. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.033 · Cited by 140
Self-citationPennlert, J., Overholser, R., Asplund, K., Carlberg, B., Rompaye, B. V., Wiklund, P.-G., & Eriksson, M. (2016) · Stroke · doi:10.1161/strokeaha.116.014643 · Cited by 139
Hsu, J. C., Maddox, T. M., Kennedy, K. F., Katz, D. F., Marzec, L., Lubitz, S. A., Gehi, A. K., Turakhia, M. P., & Marcus, G. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.581 · Cited by 140
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137
Self-citationEvaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation
Regpala, S., Lacombe, S., Sharma, M., Gibbens, S., Ball, D., Francis, K., & LaHaye, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0424 · Cited by 130
Bykov, K., Bartels, D. B., Huybrechts, K. F., Zint, K., Schneeweiß, S., & Seeger, J. D. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0497 · Cited by 136
Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Humphries, K. H., Tu, J. V., Behlouli, H., & Pilote, L. (2012) · Circulation · doi:10.1161/circulationaha.112.092494 · Cited by 138
Bekwelem, W., Connolly, S. J., Halperin, J. L., Adabag, S., Duval, S., Chrolavicius, S., Pogue, J., Ezekowitz, M. D., Eikelboom, J. W., Wallentin, L. G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013243 · Cited by 123
Hamatani, Y., Ogawa, H., Takabayashi, K., Yamashita, Y., Takagi, D., Esato, M., Chun, Y., Tsuji, H., Wada, H., Hasegawa, K., et al. (2016) · Scientific Reports · doi:10.1038/srep31042 · Cited by 136
Self-citationWide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation
Quinn, G. R., Severdija, O. N., Chang, Y., & Singer, D. E. (2017) · Circulation · doi:10.1161/circulationaha.116.024057 · Cited by 128
Perreault, S., de Denus, S., White‐Guay, B., Côté, R., Schnitzer, M. E., Dubé, M., Dorais, M., & Tardif, J. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2350 · Cited by 136
Kim, D. H., Pawar, A. M., Gagne, J. J., Bessette, L. G., Lee, H., Glynn, R. J., & Schneeweiß, S. (2021) · Annals of Internal Medicine · doi:10.7326/m20-7141 · Cited by 137
O’Shea, R. S., Davitkov, P., Ko, C. W., Rajasekhar, A., Su, G. L., Sultan, S., Allen, A. M., & Falck-Ytter, Y. T. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.015 · Cited by 138
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
Cho, M. S., Kang, D., Ahn, J., Yun, S.-C., Oh, Y., Lee, C. H., Choi, E., Lee, J. H., Kwon, C. H., Park, G., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2407362 · Cited by 136
Lin, L., Lee, C., Yu, C., Tsai, C., Lai, L.-P., Hwang, J., Chen, P., & Lin, J.-L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.033 · Cited by 135
Parikh, N. I., Jeppson, R. P., Berger, J. S., Eaton, C. B., Kroenke, C. H., LeBlanc, E. S., Lewis, C. E., Loucks, E. B., Parker, D. R., Rillamas-Sun, E., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017854 · Cited by 134
Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events
Seiffge, D. J., Traenka, C., Polymeris, A. A., Hert, L., Peters, N., Lyrer, P. A., Engelter, S. T., Bonati, L. H., & Marchis, G. M. D. (2016) · Neurology · doi:10.1212/wnl.0000000000003283 · Cited by 134
Maddox, T. M., Albert, N. M., Borden, W. B., Curtis, L. H., Ferguson, T. B., Kao, D. P., Marcus, G. M., Peterson, E. D., Redberg, R. F., Rumsfeld, J. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000480 · Cited by 137
Gorenek, B., Lundqvist, C. B., Terradellas, J. B., Camm, A. J., Hindricks, G., Huber, K., Kirchhof, P., Kuck, K.-H., Kudaiberdieva, G., Lin, T., et al. (2015) · European Heart Journal: Acute Cardiovascular Care · doi:10.1177/2048872614550583 · Cited by 128
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 134
Salman, R. A., Keerie, C., Stephen, J., Lewis, S. C., Norrie, J. D., Dennis, M. S., Newby, D. E., Wardlaw, J. M., Lip, G. Y. H., Parry‐Jones, A., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00264-7 · Cited by 134
Self-citationA practical approach to the management of cerebral amyloid angiopathy
Kozberg, M. G., Perosa, V., Gurol, M. E., & van Veluw, S. J. (2020) · International Journal of Stroke · doi:10.1177/1747493020974464 · Cited by 133
Teppo, K., Lip, G. Y. H., Airaksinen, K. E. J., Halminen, O., Haukka, J. K., Putaala, J., Mustonen, P., Linna, M., Hartikainen, J. E. K., & Lehto, M. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100967 · Cited by 134
Self-citationKarasoy, D., Gislason, G. H., Hansen, J., Johannessen, A., Køber, L., Hvidtfeldt, M., Özcan, C., Torp-Pedersen, C., & Hansen, M. L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu421 · Cited by 132
Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation
Markl, M., Lee, D. C., Furiasse, N. M., Carr, M. L., Foucar, C. E., Ng, J., Carr, J., & Goldberger, J. J. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.004984 · Cited by 133
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases
Abu-Rumeileh, S., Abdelhak, A., Foschi, M., D'Anna, L., Russo, M., Steinacker, P., Kuhle, J., Tumani, H., Blennow, K., & Otto, M. (2023) · Brain · doi:10.1093/brain/awac328 · Cited by 118
Aggarwal, R., Ruff, C. T., Virdone, S., Perreault, S., Kakkar, A. K., Palazzolo, M. G., Dorais, M., Kayani, G., Singer, D. E., Secemsky, E. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064556 · Cited by 132
Sarvari, S. I., Haugaa, K. H., Stokke, T. M., Ansari, H. Z., Leren, I. S., Hegbom, F., Smiseth, O. A., & Edvardsen, T. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev185 · Cited by 131
Takabayashi, K., Hamatani, Y., Yamashita, Y., Takagi, D., Unoki, T., Ishii, M., Iguchi, M., Masunaga, N., Ogawa, H., Esato, M., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010947 · Cited by 131
Self-citationAtherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 118
Banerjee, A., Benedetto, V., Gichuru, P., Burnell, J., Antoniou, S., SCHILLING, R. J., Strain, W. D., Ryan, R. P., Watkins, C. L., Marshall, T. P., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315307 · Cited by 132
Kunneman, M., Branda, M. E., Hargraves, I. G., Sivly, A. L., Lee, A. T., Gorr, H. S., Burnett, B., Suzuki, T., Jackson, E. A., Hess, E. P., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2908 · Cited by 131
Sharma, V., Ali, I., van der Veer, S. N., Martin, G. P., Ainsworth, J. D., & Augustine, T. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100253 · Cited by 131
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study
Thompson, P. A., Lévy, V., Tam, C. S. L., Al‐Nawakil, C., Goudot, F., Quinquenel, A., Ysebaert, L., Michallet, A., Dilhuydy, M., Neste, E. V. D., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14324 · Cited by 130
Gengler, B. E., Barasch, N. S., & Tellor, K. B. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1905 · Cited by 130
Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lópes, R. D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx584 · Cited by 131
Karlsson, L. O., Nilsson, S., Bång, M., Nilsson, L., Charitakis, E., & Janzon, M. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002528 · Cited by 120
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
Lee, S., Lee, H., Choi, E., Han, K., Jung, J., Cha, M., Oh, S., & Lip, G. Y. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.052 · Cited by 131
Self-citationBanerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs005 · Cited by 109
Self-citationKorsholm, K., Nielsen, K. M., Jensen, J. M., Jensen, H. K., Andersen, G., & Nielsen‐Kudsk, J. E. (2017) · EuroIntervention · doi:10.4244/eij-d-16-00726 · Cited by 131
Yamashita, Y., Uozumi, R., Hamatani, Y., Esato, M., Chun, Y., Tsuji, H., Wada, H., Hasegawa, K., Ogawa, H., Abe, M., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1337 · Cited by 129
Lefebvre, M. D., St‐Onge, M., Glazer‐Cavanagh, M., Bell, L., Nguyen, J. N. K., Nguyen, P. V.-Q., & Tannenbaum, C. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.012 · Cited by 129
Batra, G., Svennblad, B., Held, C., Jernberg, T., Johanson, P., Wallentin, L. C., & Oldgren, J. (2016) · Heart · doi:10.1136/heartjnl-2015-308678 · Cited by 129
O’Brien, E. C., Simon, D. N., Allen, L. A., Singer, D. E., Fonarow, G. C., Kowey, P. R., Thomas, L. E., Ezekowitz, M. D., Mahaffey, K. W., Chang, P., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.002 · Cited by 120
The Use of Dabigatran Immediately After Atrial Fibrillation Ablation
WINKLE, R. A., MEAD, R. H., ENGEL, G., KONG, M. H., & PATRAWALA, R. A. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02175.x · Cited by 121
Joundi, R. A., Cipriano, L. E., Sposato, L. A., Saposnik, G., & on behalf of the Stroke Outcomes Research Working Group (2016) · Stroke · doi:10.1161/strokeaha.115.012609 · Cited by 104
Leung, M., van Rosendael, P. J., Abou, R., Marsan, N. A., Leung, D. Y., Delgado, V., & Bax, J. J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx736 · Cited by 130
Body mass index and adverse events in patients with incident atrial fibrillation
Overvad, T. F., Rasmussen, L. H., Skjøth, F., Overvad, K., Lip, G. Y. H., & Larsen, T. B. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.11.024 · Cited by 127
Self-citationOlesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2011) · CHEST Journal · doi:10.1378/chest.11-0862 · Cited by 133
Self-citationHalvorsen, S., Ghanima, W., Tvete, I. F., Hoxmark, C., Falck, P., Solli, O., & Jonasson, C. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw031 · Cited by 129
Kwong, C., Ling, A. Y., Crawford, M. H., Zhao, S. X., & Shah, N. H. (2017) · Cardiology · doi:10.1159/000476030 · Cited by 127
Rost, N. S., Giugliano, R. P., Ruff, C. T., Murphy, S. A., Crompton, A. E., Norden, A. D., Silverman, S. B., Singhal, A. B., Nicolau, J. C., SomaRaju, B., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013540 · Cited by 127
Larsen, T. B., Gorst‐Rasmussen, A., Rasmussen, L. H., Skjøth, F., Rosenzweig, M., & Lip, G. Y. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.01.031 · Cited by 125
Self-citationStroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
Calenda, B. W., Fuster, V., Halperin, J. L., & Granger, C. B. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.106 · Cited by 125
Suzuki, S. S., Yamashita, T., Okumura, K., Atarashi, H., Akao, M., Ogawa, H., & Inoue, H. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-1131 · Cited by 125
Huang, H., Liu, Y., Xu, Y., Wang, Z., Li, Y., Cao, K., Zhang, S., Yang, Y., Yang, X., Huang, D., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.06.072 · Cited by 125
Kotecha, D., BREITHARDT, G. E., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., Arnar, D. O., Atar, D., Auricchio, A., Bax, J. J., et al. (2018) · EP Europace · doi:10.1093/europace/eux318 · Cited by 125
Self-citationGallego, P., Roldán, V., Marin, F., Gálvez, J., Valdés, M., Vicente, V., & Lip, G. Y. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.023 · Cited by 124
Self-citationRenal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 126
Self-citation
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.